Nimble Therapeutics and Genentech, a member of the Roche Group, have expanded their partnership, the company announced today. According to a release, the companies executed a license agreement for the…

Nimble Therapeutics has expanded its collaboration and executed a license agreement with Genentech, the company announced recently. According to a release, the two companies will work together on the discovery…

Nimble Therapeutics and RayzeBio, a biotech company focused on improving outcomes for people with cancer, have entered a strategic collaboration, the company announced recently. According to a release, the purpose…

Nimble Therapeutics has entered into a strategic collaboration with Incyte, a pharmaceutical company, to discover first-in-class peptide therapies across various disease areas, the company announced recently. “This is an important…

Nimble Therapeutics will collaborate with Roche Diagnostics to accelerate the discovery of novel peptide-based molecules for the development of SARS-CoV-2 in vitro diagnostic assays, the company announced today. SARS-CoV-2 is…

Nimble Therapeutics and Swedish company Svar Life Science are collaborating to discover, develop and commercialize diagnostic tests based on Nimble’s novel biomarker discovery engine, the company announced today. “We are…

Nimble Therapeutics announced recently that it will enter a multi-year collaboration with Genentech to accelerate the discovery and development of novel peptide-based medicines. According to a release, the collaboration will leverage…

Nimble Therapeutics announced today that it has spun out from F. Hoffman-La Roche as a standalone biotech company. According to a release, Nimble Therapeutics will commercialize its proprietary chemical synthesis technology for…